Larvol Delta - Anova-Announces-First-Patient-Enrolled-to-Phase-12a-Study-of-DB107-for-the-Treatment-of-HighGrade-Gliomas

vocimagene amiretrorepvec/extended release flucytosine (DB107) - Denovo

https://www.businesswire.com/news/home/20250305244241/en/Anova-Announces-First-Patient-Enrolled-to-Phase-12a-Study-of-DB107-for-the-Treatment-of-High-Grade-Gliomas

Mar 5, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next